Treatment of high-risk venous thrombosis patients using low-dose intraclot injections of recombinant tissue plasminogen activator and regional anticoagulation.

Chang, R.,Butman, J. A.,Lonser, R. R.,Sherry, R. M.,Pandalai, P. K.,Horne, M. K.,Lozier, J. N.; J Vasc Interv Radiol. 2013 Jan.

Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.

ohen, D.J., Newman, E., Iqbal, S., Chang, R.Y., Potmesil, M., Ryan, T., Donahue, B., Chandra, A., Liu, M., Utate, M., Hiotis, S., Pachter, L.H., Hochster, H., Muggia, F.; Ann Surg Oncol. 2012 Feb.

Role of family history and ethnicity on the mode and age of prostate cancer presentation.

Cotter, M.P., Gern, R.W., Ho, G.F., Chang, R.Y., Burk, R.D.; Prostate. 2002 Mar 1.